monoisoamyl-2,3-dimercaptosuccinate has been researched along with aminolevulinic acid in 4 studies
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]
Studies (monoisoamyl-2,3-dimercaptosuccinate) | Trials (monoisoamyl-2,3-dimercaptosuccinate) | Recent Studies (post-2010) (monoisoamyl-2,3-dimercaptosuccinate) | Studies (aminolevulinic acid) | Trials (aminolevulinic acid) | Recent Studies (post-2010) (aminolevulinic acid) |
---|---|---|---|---|---|
53 | 0 | 19 | 6,475 | 665 | 2,740 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flora, SJ; Jaiswal, DK; Kannan, GM; Pant, BP | 1 |
Prasad, S; Siddiqui, MK; Singh, S; Srivastava, S; Tandon, SK | 1 |
Bhaskar, AS; Dube, SN; Flora, SJ; Kannan, GM; Mehta, A; Pant, BP; Rao, PV | 1 |
Bhatt, K; Dwivedi, N; Flora, SJ; Kushwah, PK; Pachauri, V | 1 |
4 other study(ies) available for monoisoamyl-2,3-dimercaptosuccinate and aminolevulinic acid
Article | Year |
---|---|
Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats.
Topics: Aminolevulinic Acid; Animals; Arsenicals; Chelating Agents; Copper; Drug Therapy, Combination; Gallium; Glutathione; Glutathione Disulfide; Kidney; Liver; Male; Malondialdehyde; Oxalic Acid; Oxidative Stress; Porphobilinogen Synthase; Protoporphyrins; Rats; Rats, Wistar; Spleen; Succimer; Tissue Distribution; Zinc | 2002 |
Reversal of lead-induced oxidative stress by chelating agent, antioxidant, or their combination in the rat.
Topics: Acetylcysteine; Aminolevulinic Acid; Animals; Antioxidants; Brain; Catalase; Chelating Agents; Free Radical Scavengers; Glutathione; Kidney; Lead; Lead Poisoning; Male; Malondialdehyde; Oxidative Stress; Rats; Succimer | 2002 |
Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats.
Topics: Aminolevulinic Acid; Animals; Antidotes; Arsenic Poisoning; Arsenicals; Biomarkers; Chelating Agents; Chelation Therapy; Comet Assay; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Gallium; Injections, Intraperitoneal; Liver; Male; Protoporphyrins; Rats; Rats, Wistar; Succimer; Treatment Outcome | 2004 |
Co-administration of meso 2,3-dimercaptosuccinic acid monoesters reduces arsenic concentration and oxidative stress in gallium arsenide exposed rats.
Topics: Aminolevulinic Acid; Animals; Arsenic; Arsenic Poisoning; Arsenicals; Catalase; Copper; Gallium; Glutathione; Heme; Kidney; Lipid Peroxidation; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer; Superoxide Dismutase; Transaminases; Zinc | 2011 |